| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 05/02/2006 | US7037664 Apoptosis marker antibodies and methods of use |
| 05/02/2006 | US7037652 Diagnosing prostate cancer in humans; obtain tissue sample, monitor gene expression, compare to control, evaluate for cancer |
| 05/02/2006 | US7037647 Prostate-specific membrane antigen and uses thereof |
| 05/02/2006 | US7037509 Immunologically significant herpes simplex virus antigens and methods for using same |
| 05/02/2006 | US7037507 T helper cell epitopes |
| 05/02/2006 | US7037504 Resistant to proteolysis, and gene sequences encoding these forms and having codons optimized for usage by an industrial production organism, are provided. |
| 05/02/2006 | US7037498 Antibodies to insulin-like growth factor I receptor |
| 05/02/2006 | CA2149529C Peptides and anti-sense peptides with broad neoplastic specificity |
| 04/27/2006 | WO2006045116A2 In vivo site-specific incorporation of n-acetyl-galactosamine amino acids in eubacteria |
| 04/27/2006 | WO2006045049A1 Angiopoietin-2 specific binding agents |
| 04/27/2006 | WO2006044459A2 Prion protein binding materials and methods of use |
| 04/27/2006 | WO2006043701A1 Method of inhibiting phosphorylation of transcriptional factor for gluconeogenesis-associated gene and phosphorylation inhibitor |
| 04/27/2006 | WO2006043675A1 Cell extract for cell-free protein synthesis and method of preparing the extract |
| 04/27/2006 | WO2005122675A3 Optimized recognition site of the alphavirus non-structural protease for tag removal and specific processing of recombinant proetins |
| 04/27/2006 | WO2005108427A3 Method for producing soluble mhc proteins |
| 04/27/2006 | WO2005081980A3 Methods and compositions relating to chitinases and chitinase-like molecules and modulation of osteoclasts |
| 04/27/2006 | WO2005059157A3 METHODS AND COMPOSITIONS FOR USE IN PREPARING HAIRPIN RNAs |
| 04/27/2006 | WO2005034853A3 Uses of interferons with altered spatial structure |
| 04/27/2006 | WO2005018424A3 Antibodies specific for fibrillar amyloid and a procedure to detect fibrillar amyloid deposits |
| 04/27/2006 | WO2004085624A3 Transaminases, deaminases and aminomutases and compositions and methods for enzymatic detoxification |
| 04/27/2006 | US20060090212 Novel human genes and proteins encoded thereby |
| 04/27/2006 | US20060089493 Novel gene targets and ligands that bind thereto for treatment and diagnosis of colon carcinomas |
| 04/27/2006 | US20060089492 DNA comprising promoter sequence, derived from a wild-type promoter of a methyltrophic yeast, whose transcription efficiency is modulated in comparison to the efficiency of the wild-type promoter by inserting or modifying a DNA binding site |
| 04/27/2006 | US20060089306 New epilepsy mutations |
| 04/27/2006 | US20060089303 Cancer-testis antigens |
| 04/27/2006 | US20060089298 Novel substances k01-b0171 and process for producing the same |
| 04/27/2006 | US20060089283 Pectate lyase variants |
| 04/27/2006 | US20060088932 Truncated glycogen synthase kinase 3 crystallizable polypeptide; drug screening for Alzheimer's Disease treatments, antidiabetic and antiinflammatory agents |
| 04/27/2006 | US20060088920 DNA comprising a nucleotide sequence that encodes decaprenyl diphosphate (DPP) synthase |
| 04/27/2006 | US20060088917 IL-17 homologous polypeptides and therapeutic uses thereof |
| 04/27/2006 | US20060088916 IL-17 homologous polypeptides and therapeutic uses thereof |
| 04/27/2006 | US20060088915 A G protein-coupled receptor protein for the treatment of digestive diseases |
| 04/27/2006 | US20060088914 Nucleotide sequences coding uncoupling protein for use in the diagnosis and treatment of nervous system disorders |
| 04/27/2006 | US20060088913 Mutation associated with epilepsy |
| 04/27/2006 | US20060088912 Compositions and methods of purifying myelin-associated glycoprotein (MAG) |
| 04/27/2006 | US20060088911 Yeast transformation system |
| 04/27/2006 | US20060088910 RT-PCR-based cloning of the human beta-amyloid precursor protein gene and the construction of its expression plasmids |
| 04/27/2006 | US20060088909 Virus-like particles, methods of preparation, and immunogenic compositions |
| 04/27/2006 | US20060088908 Mutiens of human neutrophil gelatinase-associated lipocalin and related proteins |
| 04/27/2006 | US20060088907 Novel 13237, 18480, 2245, 16228, 7677, 26320, 46619, 33166, 16836, 46867, 21617, 55562, 39228, 62088, 46745, 23155, 21657, 42755, 32229, 22325, 46863 and 32252 molecules and uses therefor |
| 04/27/2006 | US20060088906 Forming a convalent conjugate of a peptide, EPO, removing X2 or a saccharyl subunit thereof from peptide forming a truncated glycan; contacting truncated glycan with glycosyltransferase and modified sugar donor under conditions suitable for glycosyltransferase to transfer a modified sugar moiety |
| 04/27/2006 | US20060088902 Methods and materials for the identification of antifungal substrates in filamentous fungi |
| 04/27/2006 | US20060088893 Prostate cancer therapeutics and diagnostics based on conformers of prostatic cid phosphatase |
| 04/27/2006 | US20060088889 screening the peptide library of chemically synthesized peptides, each of the peptides comprising an N-terminal or C-terminal amino acid associated with enzymatic or chemical cleavage of a polypeptide for biological activity; e.g. screening for Clostridium perfringens growth inhibitors or enhancers |
| 04/27/2006 | US20060088883 Recombinant catalytic polypeptides and their uses |
| 04/27/2006 | US20060088878 Purification of recombinant proteins fused to multiple epitopes |
| 04/27/2006 | US20060088864 Aptamer regulated nucleic acids and uses thereof |
| 04/27/2006 | US20060088854 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/27/2006 | US20060088847 ARF-BP1 as mediator of p53-dependent and independent tumor suppression and uses thereof |
| 04/27/2006 | US20060088828 Polycystic kidney disease nucleic acids and proteins |
| 04/27/2006 | US20060088825 Human delta-n p73 molecules and uses thereof |
| 04/27/2006 | US20060088824 Used in assays to identify PAP-1/WIP-1 interaction inhibitors; West Nile virus (WNV) |
| 04/27/2006 | US20060088820 Detecting superantigen activity in a biological sample |
| 04/27/2006 | US20060088577 Process for manufacturing fibrin membranes and fibrin membranes obtained according to this process |
| 04/27/2006 | US20060088551 Functional fragments of HIV-1 VPR protein and methods of using the same |
| 04/27/2006 | US20060088548 Chimeric peptides as immunogens, antibodies thereto, and methods for immunization using chimeric peptides or antibodies |
| 04/27/2006 | US20060088547 Expression, purification and uses of a Plasmodium falciparum liver stage antigen 1 polypeptide |
| 04/27/2006 | US20060088540 Antagonists and methods for inhibiting angiogenesis |
| 04/27/2006 | US20060088538 Specifically recognizing cancer cells such as non-small cell lung cancer, pancreatic cancer and gastric cancer cells; diagnosis and therapy |
| 04/27/2006 | US20060088537 Protein involved in cancer |
| 04/27/2006 | US20060088534 Human anti-factor ix/ixa antibodies |
| 04/27/2006 | US20060088532 Lymphatic and blood endothelial cell genes |
| 04/27/2006 | US20060088531 Human antibodies against human glycoprotein VI and their use |
| 04/27/2006 | US20060088529 Bispecific monoclonal antibodies to IL-12 and IL-18 |
| 04/27/2006 | US20060088526 Humanized anti-CD3 specific antibodies |
| 04/27/2006 | CA2584511A1 Phytase from buttiauxella sp. |
| 04/27/2006 | CA2583937A1 Chimeric protein |
| 04/27/2006 | CA2582462A1 Prion protein binding materials and methods of use |
| 04/26/2006 | EP1650307A2 Methods for making recombinant proteins using apoptosis inhibitors |
| 04/26/2006 | EP1650305A1 Mutants of the factor VII activating protease and methods for their detection |
| 04/26/2006 | EP1650304A2 Cloning and recombinant production of vespid venom phospholipase and immunological therapies based thereon |
| 04/26/2006 | EP1650303A2 Method for generating a substracted cDNA library and uses of the generated library |
| 04/26/2006 | EP1650221A2 Novel compounds |
| 04/26/2006 | EP1650220A2 Anti-VEGF antibodies |
| 04/26/2006 | EP1650219A1 Human toll homologues |
| 04/26/2006 | EP1649041A2 Multimeric oxidoreductases |
| 04/26/2006 | EP1649036A1 Method for producing cyclic molecules |
| 04/26/2006 | EP1649025A2 Methods of decoupling reaction scale and protein synthesis yield in batch mode |
| 04/26/2006 | EP1649005A2 P450 oxygenases and methods of use |
| 04/26/2006 | EP1649004A2 Compositions of orthogonal lysyl-trna and aminoacyl-trna synthetase pairs and uses thereof |
| 04/26/2006 | EP1649002A2 Rna processing protein complexes and uses thereof |
| 04/26/2006 | EP1649001A2 Antibodies and uses thereof |
| 04/26/2006 | EP1648939A2 Anti-vegf antibodies |
| 04/26/2006 | EP1648918A2 Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof |
| 04/26/2006 | EP1648387A2 Fugetactic proteins, compositions and methods of use |
| 04/26/2006 | EP1546328B1 High yield heterologous expression cell lines for expression of gene products with human glycosylation pattern |
| 04/26/2006 | EP1187918B1 Tek antagonists |
| 04/26/2006 | EP1147137B1 Methods for generating phosphorylation site-specific immunological reagents |
| 04/26/2006 | EP1107994B1 Monoclonal antibodies against s100 |
| 04/26/2006 | EP1105466B1 Process for purifying human papillomavirus virus-like particles |
| 04/26/2006 | EP1059353B1 Novel calpain and dna encoding the same |
| 04/26/2006 | EP1049788B1 Protein expression in baculovirus vector expression systems |
| 04/26/2006 | EP1015592B1 Bacillus thuringiensis cryet33 and cryet34 compositions and uses therefor |
| 04/26/2006 | EP1009829B1 Adipocyte-specific protein homologs |
| 04/26/2006 | EP0983302B1 Mutated ScFv-Fragment of the OKT-3 antibody |
| 04/26/2006 | EP0966536B1 Factor x analogues with a modified protease cleavage site |
| 04/26/2006 | EP0950089B1 Methods for the production of bacteria containing eukaryotic genes |
| 04/26/2006 | EP0908466B1 Anti-human lect2 antibody, cells producing the same, and method and kit for assaying the same |
| 04/26/2006 | EP0850305B1 Compounds and methods for diagnosis of tuberculosis |
| 04/26/2006 | EP0848614B1 Isolation of microdomains of caveolae and gpi-anchored proteins |